Datar Cancer Genetics

Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that relentless research, bold initiatives, sustained commitment, and an unapologetic determination to succeed against cancer will help us defeat it. We dedicate ourselves to this singular mission as if our life depends on it. Cancer is a leading cause of death globally. Despite, decades of effort and aggressive cancer treatments, cancer remains a civilizational challenge. Today, liquid biopsy is an integral part of cancer detection and management. Our scientists have developed unique customized non-invasive tests by combining analysis of molecular biomarkers and the Circulating Tumor Cells (CTCs) to make personalized cancer management from liquid biopsy, a reality.